Endothelial signaling and the molecular basis of arteriovenous malformation

被引:28
作者
Atri, Deepak [1 ]
Larrivee, Bruno [1 ,2 ]
Eichmann, Anne [1 ,3 ]
Simons, Michael [1 ,4 ]
机构
[1] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, Sect Cardiovasc Med,Dept Internal Med, New Haven, CT 06510 USA
[2] Univ Montreal, Hop Maisonneuve Rosemont, Dept Ophthalmol, Montreal, PQ, Canada
[3] Coll France, Ctr Interdisciplinary Res Biol, F-75231 Paris, France
[4] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA
关键词
Arteriovenous malformation; Notch; TGF-beta; DLL4; ALK1; ENG; RASA1; Endo-MT; HEREDITARY HEMORRHAGIC TELANGIECTASIA; MATRIX GLA PROTEIN; TO-MESENCHYMAL TRANSITION; ARTERIAL-VENOUS DIFFERENTIATION; TGF-BETA; GROWTH-FACTOR; ENDOGLIN EXPRESSION; MURINE MODEL; MOUSE MODEL; JUVENILE POLYPOSIS;
D O I
10.1007/s00018-013-1475-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Arteriovenous malformations occur when abnormalities of vascular patterning result in the flow of blood from arteries to veins without an intervening capillary bed. Recent work has revealed the importance of the Notch and TGF-beta signaling pathways in vascular patterning. Specifically, Notch signaling has an increasingly apparent role in arterial specification and suppression of branching, whereas TGF-beta is implicated in vascular smooth muscle development and remodeling under angiogenic stimuli. These physiologic roles, consequently, have implicated both pathways in the pathogenesis of arteriovenous malformation. In this review, we summarize the studies of endothelial signaling that contribute to arteriovenous malformation and the roles of genes implicated in their pathogenesis. We further discuss how endothelial signaling may contribute to vascular smooth muscle development and how knowledge of signaling pathways may provide us targets for medical therapy in these vascular lesions.
引用
收藏
页码:867 / 883
页数:17
相关论文
共 147 条
[1]
Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease [J].
Abdalla, SA ;
Letarte, M .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (02) :97-110
[2]
IDENTIFICATION OF HUMAN ACTIVIN AND TGF-BETA TYPE-I RECEPTORS THAT FORM HETEROMERIC KINASE COMPLEXES WITH TYPE-II RECEPTORS [J].
ATTISANO, L ;
CARCAMO, J ;
VENTURA, F ;
WEIS, FMB ;
MASSAGUE, J ;
WRANA, JL .
CELL, 1993, 75 (04) :671-680
[3]
A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7 [J].
Bayrak-Toydemir, Pinar ;
McDonald, Jamie ;
Alkarsu, Nurten ;
Toydemir, Reha M. ;
Calderon, Fernanda ;
Tuncali, Timur ;
Tang, Wei ;
Miller, Franklin ;
Mao, Rong .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (20) :2155-2162
[4]
Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli [J].
Benedito, Rui ;
Trindade, Alexandre ;
Hirashima, Masanori ;
Henrique, Domingos ;
da Costa, Luis Lopes ;
Rossant, Janet ;
Gill, Parkash S. ;
Duarte, Antonio .
BMC DEVELOPMENTAL BIOLOGY, 2008, 8
[5]
Clinical heterogeneity in hereditary haemorrhagic telangiectasia: Are pulmonary arteriovenous malformations more common in families linked to endoglin? [J].
Berg, JN ;
Guttmacher, AE ;
Marchuk, DA ;
Porteous, MEM .
JOURNAL OF MEDICAL GENETICS, 1996, 33 (03) :256-257
[6]
RASA1: variable phenotype with capillary and arteriovenous malformations [J].
Boon, LM ;
Mulliken, JB ;
Vikkula, M .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (03) :265-269
[7]
Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-β1 activity in endothelial cells [J].
Boström, K ;
Zebboudj, AF ;
Yao, YC ;
Lin, TS ;
Torres, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (51) :52904-52913
[8]
Matrix GLA protein modulates differentiation induced by done morphogenetic protein-2 in C3H10T1/2 cells [J].
Bostrom, K ;
Tsao, D ;
Shen, S ;
Wang, Y ;
Demer, LL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) :14044-14052
[9]
Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1 [J].
Bourdeau, A ;
Cymerman, U ;
Paquet, ME ;
Meschino, W ;
McKinnon, WC ;
Guttmacher, AE ;
Becker, L ;
Letarte, M .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :911-923
[10]
A murine model of hereditary hemorrhagic telangiectasia [J].
Bourdeau, A ;
Dumont, DJ ;
Letarte, M .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (10) :1343-1351